Clinical Trial

The Impact of Diabetes Remission on Aging

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is a real-world, prospective clinical cohort study. It will enroll Chinese patients with type 2 diabetes. The aim is to assess the changes in aging biomarkers, primarily DunedinPACE, from baseline to post-remission, and to compare these biomarkers between patients who achieve successful remission and those who do not.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT07736040
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions Type 2 Diabetes
Enrollment 100 participants
Start Date 2026-07-09
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-30